Sign In
Buy DXCM
$82.66
-4.28 (-4.92%)
At Close: Aug 05, 2026
DexCom (DXCM) Declines on Potential Competition for Stelo (revised)
02:26pm, Tuesday, 04'th Jun 2024
DexCom (DXCM) stock declined on Monday following the FDA approval of another over-the-counter glucose monitor, potentially fueling competition for Stelo.
DexCom (DXCM) Declines on Potential Competition for Stelo
07:21am, Tuesday, 04'th Jun 2024
DexCom (DXCM) stock declined on Monday following the FDA approval of another over-the-counter glucose monitor, potentially fueling competition for Stelo.
Dexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes
07:00am, Tuesday, 04'th Jun 2024
EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in acc
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
04:04pm, Monday, 03'rd Jun 2024
BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, today announced that residents of
Bull Market Buys: 2 Growth Stocks to Own for the Long Haul
07:45am, Monday, 03'rd Jun 2024
Intuitive Surgical will benefit as the need grows for procedures using its robotic devices. DexCom provides critical devices to the increasing population of diabetes patients.
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
05:50am, Thursday, 30'th May 2024
Abbott and DexCom depend heavily on continuous glucose monitoring (CGM) device sales. Vertex is developing therapies that could cure type 1 diabetes.
The 3 Best MedTech Stocks to Buy Now: May 2024
02:30pm, Wednesday, 29'th May 2024
In a recent deep-dive research report on the state of the MedTech (medical technology) sector, Oppenheimer highlighted the potential of artificial intelligence (AI) in the sector, noting its capacity
Dexcom Announces Upcoming Conference Presentation
08:30am, Wednesday, 29'th May 2024
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the William B
Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
08:30am, Wednesday, 29'th May 2024
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ technology is
3 Growth Stocks the New ‘GPT-4o' AI Bot Says Will Make You Rich
12:55pm, Monday, 27'th May 2024
OpenAI has recently released its GPT-4o AI bot, touted as a more advanced version of its previous language models. This new bot is more focused on voice inputs and usefulness in day-to-day living t
Why DexCom (DXCM) is a Top Momentum Stock for the Long-Term
10:56am, Monday, 27'th May 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
LONDON--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM d
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio Now
08:06am, Friday, 17'th May 2024
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
Will DexCom Offer Better Returns Than 3M Stock?
08:00am, Friday, 17'th May 2024
Given its better prospects, we believe DexCom stock (NASDAQ NASDAQ : DXCM) is a better pick than 3M stock (NYSE: MMM). Although these companies are from different sectors, we compare them because of t
Dexcom: Positive Catalysts Ahead To Support Growth
01:30pm, Monday, 13'th May 2024
Dexcom is a buy despite a recent slowdown in US sales. The upcoming launch of Stelo, a glucose monitor for non-insulin users, has a large potential market and is expected. Ex-US growth remains strong
